US EditionAmalgam Rx Gets $20M to Boost Medical-Grade AI™ Deployment
Summary by AI TechPark
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Amalgam Rx Gets $20M to Boost Medical-Grade AI™ Deployment
Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare companies. The funding will accelerate the scaling of Amalgam’s Medical-Grade AI solutions to further empower patients in their daily lives and providers in their clinical workflows. The senior secured term loan provides…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
